Health and Fitness Health and Fitness
Thu, April 26, 2012
Wed, April 25, 2012
Tue, April 24, 2012
Mon, April 23, 2012
Sun, April 22, 2012
Sat, April 21, 2012
Fri, April 20, 2012
Thu, April 19, 2012
Wed, April 18, 2012
Tue, April 17, 2012
Mon, April 16, 2012
Sun, April 15, 2012
[ Sun, Apr 15th 2012 ] - Market Wire
DaVita Announces CFO Transition
Sat, April 14, 2012
Fri, April 13, 2012

WuXi PharmaTech Files 2011 Annual Report on Form 20-F


Published on Friday, April 20th 2012 at 11:56 GMT by Market Wire   Print publication without navigation


WuXi PharmaTech Files 2011 Annual Report on Form 20-F -- SHANGHAI, April 20, 2012 /PRNewswire-Asia/ --

WuXi PharmaTech Files 2011 Annual Report on Form 20-F

[ ]

SHANGHAI, April 20, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: [ WX ]) today announced that it filed its annual report on Form 20-F for the year ended December 31, 2011 with the Securities and Exchange Commission.  The annual report can be accessed on WuXi PharmaTech's website at [ http://www.wuxiapptec.com ] under the Investor Relations/SEC Filings section.  WuXi PharmaTech will provide a hard copy of its annual report on Form 20-F containing complete audited financial statements free of charge to its shareholders and ADS holders upon request.  Requests should be directed to Ronald Aldridge, Director of Investor Relations, by email at [ ir@wuxiapptec.com ].

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States.  As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process.  WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D.  WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec.  For more information, please visit: [ http://www.wuxiapptec.com ] .

For more information, please contact:

WuXi PharmaTech (Cayman) Inc.
Ronald Aldridge (for investors)
Director of Investor Relations
Tel: +1-201-585-2048
Email: [ ir@wuxiapptec.com ]

Harry He (for the media)
Tel: +86-21-5046-4362
Email: [ pr@wuxiapptec.com ]

SOURCE WuXi PharmaTech (Cayman) Inc.

[ Back to top ]

RELATED LINKS
[ http://www.wuxiapptec.com ]


Publication Contributing Sources